Author:
Gokare Prashanth,Finnberg Niklas K.,Abbosh Phillip H.,Dai Jenny,Murphy Maureen E.,El-Deiry Wafik S.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Wasternack, C. Degradation of pyrimidines and pyrimidine analogs–pathways and mutual influences. Pharmacol Ther 8, 629–651 (1980).
2. Shaul, Y. D. et al. Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell 158, 1094–1109, doi:
10.1016/j.cell.2014.07.032
(2014).
3. Danneberg, P. B., Montag, B. J. & Heidelberger, C. Studies on fluorinated pyrimidines. IV. Effects on nucleic acid metabolism in vivo. Cancer Res 18, 329–334 (1958).
4. Heidelberger, C. et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179, 663–666 (1957).
5. Kline, C. L. et al. Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients. Cancer Biol Ther 12, 557–568 (2011).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献